Leukotriene B4 MaxSpec® Standard 10 µg | ≥95%
Cayman Chemical
A quantitative analytical standard guaranteed to meet MaxSpec® identity, purity, stability, and concentration specifications
More Information Supplier PageA quantitative analytical standard guaranteed to meet MaxSpec® identity, purity, stability, and concentration specifications
More Information Supplier Page
Potent Bcl-2 family inhibitor, inhibits Bcl-2, Bcl-xL, and Bcl-w Apoptosis|Bcl-2 Family
More Information Supplier Page(+)-Cedryl acetate is a sesquiterpene compound, which is derived from natural oils found to be volatile in nature.
More Information Supplier Page
(+)-Cembrene A is a α-glucosidase inhibitor with an IC 50 of 30.31 μM. (+)-Cembrene A is nontoxic towards human normal hepatocyte (LO2) cells .
More Information Supplier Page
(+)-Cembrene A is a α-glucosidase inhibitor with an IC 50 of 30.31 μM. (+)-Cembrene A is nontoxic towards human normal hepatocyte (LO2) cells .
More Information Supplier Page(+)-Cembrene A is a α-glucosidase inhibitor with an IC 50 of 30.31 μM. (+)-Cembrene A is nontoxic towards human normal hepatocyte (LO2) cells .
More Information Supplier Page
(+)-Cevimeline hydrochloride hemihydrate ((+)-SNI-2011) is a potent muscarinic receptor agonist that is a candidate therapeutic drug for xerostomia in Sjogren’s syndrome. IC50 value: Target: mAChR The general pharmacol. properties of this drug on the gastrointestinal, urinary, and reproductive systems and other tissues were investigated in mice, rats, guinea pigs, rabbits, and dogs. The in vitro […]
More Information Supplier Page
(+)-Cevimeline hydrochloride hemihydrate ((+)-SNI-2011) is a potent muscarinic receptor agonist that is a candidate therapeutic drug for xerostomia in Sjogren’s syndrome. IC50 value: Target: mAChR The general pharmacol. properties of this drug on the gastrointestinal, urinary, and reproductive systems and other tissues were investigated in mice, rats, guinea pigs, rabbits, and dogs. The in vitro […]
More Information Supplier Page
(+)-Cevimeline hydrochloride hemihydrate ((+)-SNI-2011) is a potent muscarinic receptor agonist that is a candidate therapeutic drug for xerostomia in Sjogren’s syndrome. IC50 value: Target: mAChR The general pharmacol. properties of this drug on the gastrointestinal, urinary, and reproductive systems and other tissues were investigated in mice, rats, guinea pigs, rabbits, and dogs. The in vitro […]
More Information Supplier Page